Numerous studies have reported that CaMKII plays an important role in the development of cardiac hypertrophy through the activation of impaired gene expression of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), beta-myosin heavy chain (β-MHC), and skeletal actin [32]. This evidence concerns the gene NPPB and cardiac hypertrophy.